This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gotlib J, Cools J, Malone III JM, Schrier SL, Gilliland DG, Coutre SE . The FIP1L1-PDGFRá fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification and management. Blood 2004; 103: 2879–2891.
Klion AD, Robyn J, Akin C, Noel P, Brown M, Law M et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 2004; 103: 473–478.
Schaller JL, Burkland GA . Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. Med Gen Med 2001; 3: 9.
Archimbaud E, Guyotat D, Guillame C, Godard J, Fiere D . Hypereosinophilic syndrome with multiple organ dysfunction treated by allogeneic bone marrow transplantation. Am J Hematol 1988; 27: 302–303.
Juvonen E, Volin L, Koponen A, Ruutu T . Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome. Bone Marrow Transplant 2002; 29: 457–458.
Roche-Lestienne C, Lepers S, Soenen-Cornu V, Kahn JE, Lai JL, Hachulla E et al. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia 2005; 19: 792–798.
Tefferi A . Modern diagnosis and treatment of primary eosinophilia. Acta Haematol 2005; 114: 52–60.
Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 2004; 104: 3038–3045.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Halaburda, K., Prejzner, W., Szatkowski, D. et al. Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript. Bone Marrow Transplant 38, 319–320 (2006). https://doi.org/10.1038/sj.bmt.1705437
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705437
This article is cited by
-
Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia
Annals of Hematology (2014)
-
Response to imatinib mesylate in patients with hypereosinophilic syndrome
International Journal of Hematology (2012)